Helixis, a newly formed molecular diagnostics firm based in Carlsbad, Calif., announced this week that it has raised $10 million in a Series A round of funding.
 
The firm was co-founded by Alex Dickinson, a former CEO of Luxtera who serves as Helixis’ CEO; David Baltimore, president emeritus and Robert Andrews Millikan professor of biology at the California Institute of Technology; and Axel Scherer, professor of electrical engineering, applied physics and physics at Caltech.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.